10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lipid nephrotoxicity mediated by HIF-1α activation accelerates tubular injury in diabetic nephropathy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study is intended to explore the effect of hypoxia-inducible factor-1α (HIF-1α) activation on lipid accumulation in the diabetic kidney. A type 1 diabetic rat model was established by STZ intraperitoneal injection. Cobalt chloride (CoCl 2) and YC-1 were used as the HIF-1α activator and antagonist, respectively. CoCl 2 treatment significantly increased HIF-1α expression, accelerated lipid deposition, and accelerated tubular injury in diabetic kidneys. In vitro, CoCl 2 effectively stabilized HIF-1α and increased its transportation from the cytoplasm to the nucleus, which was accompanied by significantly increased lipid accumulation in HK-2 cells. Furthermore, results obtained in vivo showed that HIF-1α protein expression in the renal tubules of diabetic rats was significantly downregulated by YC-1 treatment. Meanwhile, lipid accumulation in the tubules of the DM + YC-1 group was markedly decreased in comparison to the DM + DMSO group. Accordingly, PAS staining revealed that the pathological injury caused to the tubular epithelial cells was alleviated by YC-1 treatment. Furthermore, the blood glucose level, urine albumin creatinine ratio, and NAG creatinine ratio in the DM + YC-1 group were significantly decreased compared to the DM + DMSO group. Moreover, the protein expression levels of transforming growth factor β1 (TGF-β1) and connective tissue growth factor (CTGF) in diabetic kidneys were decreased by YC-1 treatment. Our findings demonstrate that the activation of HIF-1α contributed to interstitial injury in a rat model of diabetic nephropathy and that the underlying mechanism involved the induction of lipid accumulation.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

          Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and regulates iron metabolism. Additional data are needed regarding the effectiveness and safety of roxadustat as compared with standard therapy (epoetin alfa) for the treatment of anemia in patients undergoing dialysis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.

            Hypoxia-inducible factors (HIFs) are transcriptional activators that function as master regulators of oxygen homeostasis, which is disrupted in disorders affecting the circulatory system and in cancer. The role of HIFs in these diseases has been elucidated by clinical studies and by analyses of mouse models. HIFs play a protective role in the pathophysiology of myocardial ischemia due to coronary artery disease, limb ischemia due to peripheral arterial disease, pressure-overload heart failure, wound healing, and chronic rejection of organ transplants. In contrast, HIFs contribute to the pathogenesis of pulmonary arterial hypertension, systemic hypertension associated with sleep apnea, ocular neovascularization, hereditary erythrocytosis, and cancer.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

                Bookmark

                Author and article information

                Journal
                Ren Fail
                Ren Fail
                Renal Failure
                Taylor & Francis
                0886-022X
                1525-6049
                2 May 2024
                2024
                2 May 2024
                : 46
                : 1
                : 2347446
                Affiliations
                Department of Pathophysiology, School of Basic Medicine, Wannan Medical College , Wuhu, China
                Author notes
                CONTACT Zebo Hu huzb0007@ 123456163.com Department of Pathophysiology, School of Basic Medicine, Wannan Medical College , Wuhu 241002, China
                Article
                2347446
                10.1080/0886022X.2024.2347446
                11067561
                38695335
                362e840e-e7c1-430a-84db-a2ebeb7cb89e
                © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

                History
                Page count
                Figures: 5, Tables: 0, Pages: 11, Words: 5290
                Categories
                Research Article
                Basic Sciences Investigations

                Nephrology
                diabetic nephropathy,hif-1α,yc-1,lipid accumulation,tubules,hk-2
                Nephrology
                diabetic nephropathy, hif-1α, yc-1, lipid accumulation, tubules, hk-2

                Comments

                Comment on this article